Business Context and Reporting Period
Company: Analog Devices, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: February 3, 2007 (Fiscal Q1 2007)
Reporting Note: Fiscal 2007 is a 53-week year; this quarter included 14 weeks of operations compared to 13 weeks in the prior year period (ended January 28, 2006).
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Total Revenue | $691.6 million | $621.3 million |
| Product Revenue | $656.6 million | $621.3 million |
| Gross Margin | $417.0 million (60.3%) | $360.8 million (58.1%) |
| Operating Income | $163.2 million | $132.2 million |
| Net Income | $153.2 million | $120.6 million |
| Diluted EPS | $0.44 | $0.32 |
| Cash from Operations | $208.2 million | $175.3 million |
| Cash & Short-term Investments | $1,953.8 million | $2,128.3 million (Oct 28, 2006) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 11% ($70.3 million). This was driven by the additional week of operations and a one-time $35 million licensing payment for intellectual property rights.
- Margin Expansion: Gross margin percentage improved by 220 basis points to 60.3%, primarily due to the high-margin licensing revenue which had no associated cost of sales.
- Operating Expenses: R&D expenses rose 10% and SG&A expenses rose 9%, largely attributed to the extra week of operations and increased headcount/salaries.
- Special Charges: The company recorded $5.2 million in special charges related to the closure of a wafer fabrication facility and reorganization of product development programs.
- Nonoperating Income: Increased significantly due to a $7.9 million gain on the sale of an investment and higher interest income.
Guidance, Outlook, and Risks
Outlook for Q2 2007 (13-week quarter)
- Revenue: Planned range of $640 million to $670 million.
- Gross Margin: Planned range of 57.7% to 58.3%.
- Diluted EPS: Planned range of $0.31 to $0.36.
- Expenses: Operating expenses are expected to increase slightly due to annual salary increases and higher R&D spending on new analog products.
Risks and Contingencies
- SEC Investigation: A tentative settlement regarding stock option granting practices (1998-2001) is pending. The company faces a potential $3 million civil penalty and option repricing for directors/CEO, but no financial restatement is expected.
- Legal Proceedings: Ongoing patent litigation with Biax Corporation and Linear Technology Corp. (LTC). The company believes these will not have a material adverse effect.
- Restructuring: Approximately $7 million in remaining expenses related to the wafer facility closure are expected in Q2 2007.
- Market Risks: Exposure to cyclical semiconductor demand, currency fluctuations (71% of revenue from international markets), and reliance on third-party foundries (e.g., TSMC).
Investor Verification Checklist
- Licensing Revenue: Verify the sustainability of the $35 million one-time IP licensing payment included in Q1 revenue.
- Restructuring Costs: Monitor the execution of the remaining $7 million in closure costs for the California wafer facility in Q2.
- Stock Repurchases: Note the aggressive buyback activity ($333.2 million in Q1) and the remaining $979 million authorized under the $3 billion program.
- Legal Settlements: Track the finalization of the SEC settlement regarding stock option backdating and the outcome of the Linear Technology patent lawsuit.
- Q2 Guidance: Compare actual Q2 results against the provided revenue ($640M-$670M) and EPS ($0.31-$0.36) ranges.